Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With Opioid Induced Constipation

Trial Profile

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With Opioid Induced Constipation

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Naloxegol (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Acronyms NACASY
  • Sponsors Kyowa Kirin Pharmaceutical Development
  • Most Recent Events

    • 26 Feb 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Nov 2019.
    • 26 Feb 2019 Status changed from not yet recruiting to recruiting.
    • 27 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top